← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
Stryker kept compounding medtech revenue and FCF, with dividends covered and acquisitions expanding the MedSurg and Neurotechnology portfolio.
The read at a glance✓ Audited against SEC data
- Growth — $25.12B revenue, up from $22.59BOK
- Profitability — $4.89B operating income; $3.25B net incomeOK
- Balance sheet — Cash/debt N/ANote
- Accounting quality — Grey Z screen; no Beneish flag; EQ N/ANote
- Capital allocation — $4.28B FCF covered $1.28B dividends; repurchases N/AOK
- Portfolio — MedSurg, Neurotechnology and Orthopaedics; no full segment bridge shownNote
Business
Stryker is a medical technology company selling products and services across MedSurg, Neurotechnology and Orthopaedics. Its products include surgical equipment, endoscopy, patient handling, emergency medical equipment, clinical communication, vascular and neuro cranial products, implants and Mako robotic-arm assisted technology.
Where the revenue comes from
Fiscal 2025, as STRYKER CORP reports it. History and quarterly detail are in the app.
- MedSurg and Neurotechnology$15.6B
- Orthopaedics$9.5B
Leadership changes
From STRYKER CORP's own filings, the day they're filed.
- Spencer Stiles · President · appointmenteff. 2026-01-01
- Dylan Crotty · President · appointmenteff. 2026-01-01
- Preston W. Wells · President · appointmenteff. 2025-04-01
Latest filings
- 10-Q · Quarterly report2026-07-31
- 8-K · Company announcement2026-07-30
- 8-K · Company announcement2026-06-26
- 8-K · Company announcement2026-05-20
- 10-Q · Quarterly report2026-05-11
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about STRYKER CORP, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.